Agnarelli, A.; Vella, V.; Samuels, M.; Papanastasopoulos, P.; Giamas, G.
Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers 2022, 14, 4378.
https://doi.org/10.3390/cancers14184378
AMA Style
Agnarelli A, Vella V, Samuels M, Papanastasopoulos P, Giamas G.
Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers. 2022; 14(18):4378.
https://doi.org/10.3390/cancers14184378
Chicago/Turabian Style
Agnarelli, Alessandro, Viviana Vella, Mark Samuels, Panagiotis Papanastasopoulos, and Georgios Giamas.
2022. "Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications" Cancers 14, no. 18: 4378.
https://doi.org/10.3390/cancers14184378
APA Style
Agnarelli, A., Vella, V., Samuels, M., Papanastasopoulos, P., & Giamas, G.
(2022). Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. Cancers, 14(18), 4378.
https://doi.org/10.3390/cancers14184378